Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Metreleptin in Anorexia Nervosa [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating metreleptin for anorexia nervosa is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYALEPT (METRELEPTIN)

Snippet

Sponsor: Gabriella Milos | Conditions: Anorexia Nervosa | Phase 2 | Status: RECRUITING